Remote Patient Monitoring: Clinical Trials

3 trials of Remote Patient Monitoring, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 suspended, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 1, Suspended 1, Withdrawn 1

Follow Remote Patient Monitoring: new trials by email Literature Review of Remote Patient Monitoring trials Research Report on Remote Patient Monitoring

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma
Phase 2SuspendedNational Cancer Institute (NCI)842024-08-272026-10-19
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Home Health Encounter, Nivolumab, Patient Monitoring - Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma
Phase 2RecruitingMayo Clinic502024-04-302026-10-02
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women
Carboplatin, Cisplatin, Paclitaxel - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma
Phase 2WithdrawnAIDS Malignancy Consortium2022-05-312022-06-21

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  HIV Infections (1)  ·  Melanoma (1)  ·  Multiple Myeloma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

AIDS Malignancy Consortium (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  South Africa (1)  ·  Zimbabwe (1)

Top investigators

Ntokozo Ndlovu (1)  ·  Roxana S. Dronca, M.D. (1)  ·  Sascha A Tuchman (1)

NIH funding

U10CA180821 (1), UM1CA121947 (1)